OptiBiotix surges as SlimBiome granted CE mark and medical device status
The CE mark allows the product to be marketed within the EEA, as well as providing eligibility for shortened medical product registration in markets such as China and the UAE
Company
OptiBiotix Health PLC
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 12 of 29
Investments and investor services
FTSE 100 closes in the red as Brexit and trade worries dampen the mood
Footsie closed the day down around 19 points at 7,016, with big miners in the losers list.
Archive
Proactive news snapshot: Union Jack Oil, Europa Oil & Gas, Bluejay Mining, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Minds + Machines on the march after non-exec buys shares
A look at the day's winners and sinners, including Bigblu, Hardy Oil & Gas, Urals Energy, Juridica, Ebiquity, Egdon Resources, Union Jack Oil, Europa Oil & Gas, Wynnstay, Veltyco and Centrica
OptiBiotix Health inks distribution deal covering Greece and Cyprus
The unnamed local partner for CholBiome was chosen for its distribution network
FTSE 100 closes firmly in the red as PM Theresa May says Brexit deal within grasp
The UK blue-chip benchmark closed down nearly 90 points at 6,960, while the FTSE 250 shed nearly 55 points
OptiBiotix boss Stephen O’Hara highlights recent direct share purchases in Proactive interview
“It’s really reassuring to ourselves within OptiBiotix and hopefully to investors that two big industry players…have committed large amounts of money to the company”
Archive
Proactive news snapshot: OptiBiotix, Minds + Machines, Savannah Resources...
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix inks agreement to manufacture LPLDL in US market
The biotech firm said under the agreement, US Pharma Lab Inc (USPL) would be granted non-exclusive rights to manufacture and supply formulations containing the LPLDL strain
Archive
Proactive news snapshot: Strategic Minerals, Nektan, G3 Exploration...
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix Health unveils second distribution deal of the week for weight management product
It is teaming up with South Africa’s Formulation Creations, led by Gary Coulson, an industry expert with an “extensive network of customers and partners” in his local market
Investments and investor services
FTSE 100 closes higher midweek, but Tesco takes a hit
Mid-cap cousin FTSE 250 also closed in positive territory - up around 35 points to stand at 20,300
Archive
Proactive news snapshot: Greatland Gold, European Metals, Chesnara, BigDish...
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix Health agrees functional foods deal with CTC Group
The pioneer of the human microbiome, the bacteria that inhabit the gut and skin, will work with CTC which will distribute weight management product SlimBiome in the Philippines, Vietnam, Indonesia and Colombia
FTSE 100 closes in red; Royal Mail delivers share plunge
The UK blue-chip index closed down around 14 points at 7,495 as the stronger pound weighed
Archive
Proactive news snapshot: Amryt Pharma, Directa Plus, Live Company...
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix Health inks Bulgarian deal for cholesterol product
The agreement grants the company's new partner exclusive distribution in return for local product registration
Archive
Proactive news snapshot: Eurasia Mining, Mosman Oil & Gas, Instem …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Market movers: N4 Pharma gets boost from the Men (and women) from EUNCL; Zinc Media surges after bagging several commissions
A look at the day's movers and shakers, featuring N4 Pharma, Zin Media, Rurelec, Trinity Exploration, Hurricane Energy, Thomas Cook, Gama Aviation, CyanConnode and Mosman
OptiBiotix planning spin-out of cholesterol and blood pressure technology as it appoints City veteran Reynolds to chair new business
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,